Coherus Oncology (CHRS) Market Capitalization (2014 - 2026)

Coherus Oncology has disclosed Market Capitalization across 13 years of filings, most recently posting $216.3 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 154.89% year-over-year to $216.3 million; the TTM figure through Jun 2026 stood at $216.3 million (up 154.89% YoY), while the FY2025 annual figure was $172.0 million, up 7.83% from the prior year.
• Market Capitalization came in at $216.3 million for Q2 2026 at Coherus Oncology, down from $260.6 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $998.4 million in Q1 2022 to a low of $84.8 million in Q2 2025.
• Average Market Capitalization over 5 years is $357.6 million, with a median of $265.9 million recorded in 2024.
• Year-over-year, Market Capitalization plunged 70.64% in 2024 and jumped 177.6% in 2026.
• Over 5 years, Market Capitalization stood at $624.5 million in 2022, then slumped by 40.16% to $373.7 million in 2023, then slumped by 57.3% to $159.5 million in 2024, then rose by 7.83% to $172.0 million in 2025, then climbed by 25.7% to $216.3 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $216.3 million in Q2 2026, $260.6 million in Q1 2026, and $172.0 million in Q4 2025.